Global Diabetes Drug Therapy Market Size, Status and Forecast 2020-2026

Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.

Market Analysis and Insights: Global Diabetes Drug Therapy Market
The global Diabetes Drug Therapy market size is projected to reach US$ 10000 million by 2026, from US$ 9009 million in 2020, at a CAGR of 10.0%% during 2021-2026.

Global Diabetes Drug Therapy Scope and Market Size
Diabetes Drug Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Drug Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG

Market segment by Type, the product can be split into

Glucagon-likepeptide-1 (GLP-1)agonist
Dipeptidyl-peptidase-4 (DPP-4)inhibitors
Sodium glucoseco-transporter 2 (SGLT2)inhibitors
Insulin
Others

Market segment by Application, split into

Type1 Diabetes
Type2 Diabetes
GestationalDiabetes
ImpairedGlucoseToleranceandImpairedFasting Glycaemia

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India